Trial intelligence / Profile preview

Vitamin D Supplementation for Cognitive Function in Schizophrenia

NCT03284294Phase 3Unknown

Sponsor
Universitas Padjadjaran
Start
Apr 2020
Primary completion
Aug 2020
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
01

Overview

A Phase 3 trial of vitamin d in schizophrenia, sponsored by Universitas Padjadjaran. Status: unknown.

02

Drugs

vitamin d
03

Conditions

schizophrenia

Beyond the preview

Go deeper on NCT03284294.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03284294.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call